A concise update on the status of liver transplantation for hepatitis B virus: The challenges in 2002
Significant improvements in both patient and graft survival after orthotopic liver transplantation (OLT) for hepatitis B virus (HBV)-related liver failure have been made during the last decade. Recurrence of HBV infection has decreased, even in high-risk patients. Despite ongoing progress, challenge...
Gespeichert in:
| Veröffentlicht in: | Liver Transplantation 2002-01, Vol.8 (1), p.2-9 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 9 |
|---|---|
| container_issue | 1 |
| container_start_page | 2 |
| container_title | Liver Transplantation |
| container_volume | 8 |
| creator | Vargas, Hugo E. Dodson, Forrest S. Rakela, Jorge |
| description | Significant improvements in both patient and graft survival after orthotopic liver transplantation (OLT) for hepatitis B virus (HBV)-related liver failure have been made during the last decade. Recurrence of HBV infection has decreased, even in high-risk patients. Despite ongoing progress, challenges remain for the next millennium, including the determination of cost-effective dosing strategies, treatment of HBV infection in liver transplant recipients, and ramifications of the use of new antiviral agents, specifically, the appearance of resistant strains. This review summarizes the relevant history of OLT for chronic viral hepatitis B, details accepted preventive and therapeutic treatments, and discusses ongoing experimental trials. Emphasis also is placed on new approaches in transplantation as they impact on the care of HBV-infected patients. (Liver Transpl 2002;8:2-9.) |
| doi_str_mv | 10.1053/jlts.2002.29765 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71404322</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1527646502022207</els_id><sourcerecordid>1257863817</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5322-ca95c82b26d976bbf69994e5712783ce60cfb72aa85b4ed20569f96de5569ee73</originalsourceid><addsrcrecordid>eNqFkc1v3CAQxVHVKF_NubeKU9XLbgAbMLklUdNGWimX7RlhPM4SeW2HwRvlvy_urppTmxMD-r3HmxlCPnO25EwWl09dwqVgTCyF0Up-IKdcCr1QpS4-_q2VPCFniE-McS4NOyYnnGtjSm1OCVxTP_Q-INBpbFwCOvQ0bYBicmlCOrS0CzuINEXX49i5Pr-HzLRDpBsY8yUFpDd0F-KEV3SdpX7jug76R0Aaejqn-0SOWtchXBzOc_Lr7vv69udi9fDj_vZ6tfCyEGLhnZG-ErVQTe6mrltlckyQmgtdFR4U822thXOVrEtoBJPKtEY1IHMBoItz8nXvO8bheQJMdhvQQ5djwzCh1bxkZf4pg9_-C3IhdaWKis-el3vUxwExQmvHGLYuvlrO7LwEOy_Bzm3aP0vIii8H86neQvPGH6aegWoPvIQOXt_zs6u1ZIxVjLM5uNlLIY9xFyBa9AF6D02I4JNthvDPXL8B1yWmrw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1257863817</pqid></control><display><type>article</type><title>A concise update on the status of liver transplantation for hepatitis B virus: The challenges in 2002</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Alma/SFX Local Collection</source><creator>Vargas, Hugo E. ; Dodson, Forrest S. ; Rakela, Jorge</creator><creatorcontrib>Vargas, Hugo E. ; Dodson, Forrest S. ; Rakela, Jorge</creatorcontrib><description>Significant improvements in both patient and graft survival after orthotopic liver transplantation (OLT) for hepatitis B virus (HBV)-related liver failure have been made during the last decade. Recurrence of HBV infection has decreased, even in high-risk patients. Despite ongoing progress, challenges remain for the next millennium, including the determination of cost-effective dosing strategies, treatment of HBV infection in liver transplant recipients, and ramifications of the use of new antiviral agents, specifically, the appearance of resistant strains. This review summarizes the relevant history of OLT for chronic viral hepatitis B, details accepted preventive and therapeutic treatments, and discusses ongoing experimental trials. Emphasis also is placed on new approaches in transplantation as they impact on the care of HBV-infected patients. (Liver Transpl 2002;8:2-9.)</description><identifier>ISSN: 1527-6465</identifier><identifier>EISSN: 1527-6473</identifier><identifier>DOI: 10.1053/jlts.2002.29765</identifier><identifier>PMID: 11799479</identifier><language>eng</language><publisher>Philadelphia, PA: Elsevier Inc</publisher><subject>Antiviral agents ; Clinical trials ; DNA, Viral - analysis ; Hepatitis B ; Hepatitis B virus ; Hepatitis B virus - genetics ; Hepatitis B, Chronic - mortality ; Hepatitis B, Chronic - surgery ; Humans ; Immunization, Passive ; Immunoglobulins - therapeutic use ; Lamivudine - therapeutic use ; Liver diseases ; Liver transplantation ; Liver Transplantation - economics ; Recurrence ; Reviews ; Risk groups ; Survival</subject><ispartof>Liver Transplantation, 2002-01, Vol.8 (1), p.2-9</ispartof><rights>2002 American Association for the Study of Liver Diseases</rights><rights>Copyright © 2002 American Association for the Study of Liver Diseases</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5322-ca95c82b26d976bbf69994e5712783ce60cfb72aa85b4ed20569f96de5569ee73</citedby><cites>FETCH-LOGICAL-c5322-ca95c82b26d976bbf69994e5712783ce60cfb72aa85b4ed20569f96de5569ee73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1053%2Fjlts.2002.29765$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1053%2Fjlts.2002.29765$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>313,314,776,780,788,1411,27899,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11799479$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vargas, Hugo E.</creatorcontrib><creatorcontrib>Dodson, Forrest S.</creatorcontrib><creatorcontrib>Rakela, Jorge</creatorcontrib><title>A concise update on the status of liver transplantation for hepatitis B virus: The challenges in 2002</title><title>Liver Transplantation</title><addtitle>Liver Transpl</addtitle><description>Significant improvements in both patient and graft survival after orthotopic liver transplantation (OLT) for hepatitis B virus (HBV)-related liver failure have been made during the last decade. Recurrence of HBV infection has decreased, even in high-risk patients. Despite ongoing progress, challenges remain for the next millennium, including the determination of cost-effective dosing strategies, treatment of HBV infection in liver transplant recipients, and ramifications of the use of new antiviral agents, specifically, the appearance of resistant strains. This review summarizes the relevant history of OLT for chronic viral hepatitis B, details accepted preventive and therapeutic treatments, and discusses ongoing experimental trials. Emphasis also is placed on new approaches in transplantation as they impact on the care of HBV-infected patients. (Liver Transpl 2002;8:2-9.)</description><subject>Antiviral agents</subject><subject>Clinical trials</subject><subject>DNA, Viral - analysis</subject><subject>Hepatitis B</subject><subject>Hepatitis B virus</subject><subject>Hepatitis B virus - genetics</subject><subject>Hepatitis B, Chronic - mortality</subject><subject>Hepatitis B, Chronic - surgery</subject><subject>Humans</subject><subject>Immunization, Passive</subject><subject>Immunoglobulins - therapeutic use</subject><subject>Lamivudine - therapeutic use</subject><subject>Liver diseases</subject><subject>Liver transplantation</subject><subject>Liver Transplantation - economics</subject><subject>Recurrence</subject><subject>Reviews</subject><subject>Risk groups</subject><subject>Survival</subject><issn>1527-6465</issn><issn>1527-6473</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1v3CAQxVHVKF_NubeKU9XLbgAbMLklUdNGWimX7RlhPM4SeW2HwRvlvy_urppTmxMD-r3HmxlCPnO25EwWl09dwqVgTCyF0Up-IKdcCr1QpS4-_q2VPCFniE-McS4NOyYnnGtjSm1OCVxTP_Q-INBpbFwCOvQ0bYBicmlCOrS0CzuINEXX49i5Pr-HzLRDpBsY8yUFpDd0F-KEV3SdpX7jug76R0Aaejqn-0SOWtchXBzOc_Lr7vv69udi9fDj_vZ6tfCyEGLhnZG-ErVQTe6mrltlckyQmgtdFR4U822thXOVrEtoBJPKtEY1IHMBoItz8nXvO8bheQJMdhvQQ5djwzCh1bxkZf4pg9_-C3IhdaWKis-el3vUxwExQmvHGLYuvlrO7LwEOy_Bzm3aP0vIii8H86neQvPGH6aegWoPvIQOXt_zs6u1ZIxVjLM5uNlLIY9xFyBa9AF6D02I4JNthvDPXL8B1yWmrw</recordid><startdate>200201</startdate><enddate>200201</enddate><creator>Vargas, Hugo E.</creator><creator>Dodson, Forrest S.</creator><creator>Rakela, Jorge</creator><general>Elsevier Inc</general><general>W.B. Saunders</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>200201</creationdate><title>A concise update on the status of liver transplantation for hepatitis B virus: The challenges in 2002</title><author>Vargas, Hugo E. ; Dodson, Forrest S. ; Rakela, Jorge</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5322-ca95c82b26d976bbf69994e5712783ce60cfb72aa85b4ed20569f96de5569ee73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Antiviral agents</topic><topic>Clinical trials</topic><topic>DNA, Viral - analysis</topic><topic>Hepatitis B</topic><topic>Hepatitis B virus</topic><topic>Hepatitis B virus - genetics</topic><topic>Hepatitis B, Chronic - mortality</topic><topic>Hepatitis B, Chronic - surgery</topic><topic>Humans</topic><topic>Immunization, Passive</topic><topic>Immunoglobulins - therapeutic use</topic><topic>Lamivudine - therapeutic use</topic><topic>Liver diseases</topic><topic>Liver transplantation</topic><topic>Liver Transplantation - economics</topic><topic>Recurrence</topic><topic>Reviews</topic><topic>Risk groups</topic><topic>Survival</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vargas, Hugo E.</creatorcontrib><creatorcontrib>Dodson, Forrest S.</creatorcontrib><creatorcontrib>Rakela, Jorge</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Liver Transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vargas, Hugo E.</au><au>Dodson, Forrest S.</au><au>Rakela, Jorge</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A concise update on the status of liver transplantation for hepatitis B virus: The challenges in 2002</atitle><jtitle>Liver Transplantation</jtitle><addtitle>Liver Transpl</addtitle><date>2002-01</date><risdate>2002</risdate><volume>8</volume><issue>1</issue><spage>2</spage><epage>9</epage><pages>2-9</pages><issn>1527-6465</issn><eissn>1527-6473</eissn><abstract>Significant improvements in both patient and graft survival after orthotopic liver transplantation (OLT) for hepatitis B virus (HBV)-related liver failure have been made during the last decade. Recurrence of HBV infection has decreased, even in high-risk patients. Despite ongoing progress, challenges remain for the next millennium, including the determination of cost-effective dosing strategies, treatment of HBV infection in liver transplant recipients, and ramifications of the use of new antiviral agents, specifically, the appearance of resistant strains. This review summarizes the relevant history of OLT for chronic viral hepatitis B, details accepted preventive and therapeutic treatments, and discusses ongoing experimental trials. Emphasis also is placed on new approaches in transplantation as they impact on the care of HBV-infected patients. (Liver Transpl 2002;8:2-9.)</abstract><cop>Philadelphia, PA</cop><pub>Elsevier Inc</pub><pmid>11799479</pmid><doi>10.1053/jlts.2002.29765</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1527-6465 |
| ispartof | Liver Transplantation, 2002-01, Vol.8 (1), p.2-9 |
| issn | 1527-6465 1527-6473 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_71404322 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Alma/SFX Local Collection |
| subjects | Antiviral agents Clinical trials DNA, Viral - analysis Hepatitis B Hepatitis B virus Hepatitis B virus - genetics Hepatitis B, Chronic - mortality Hepatitis B, Chronic - surgery Humans Immunization, Passive Immunoglobulins - therapeutic use Lamivudine - therapeutic use Liver diseases Liver transplantation Liver Transplantation - economics Recurrence Reviews Risk groups Survival |
| title | A concise update on the status of liver transplantation for hepatitis B virus: The challenges in 2002 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T21%3A55%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20concise%20update%20on%20the%20status%20of%20liver%20transplantation%20for%20hepatitis%20B%20virus:%20The%20challenges%20in%202002&rft.jtitle=Liver%20Transplantation&rft.au=Vargas,%20Hugo%20E.&rft.date=2002-01&rft.volume=8&rft.issue=1&rft.spage=2&rft.epage=9&rft.pages=2-9&rft.issn=1527-6465&rft.eissn=1527-6473&rft_id=info:doi/10.1053/jlts.2002.29765&rft_dat=%3Cproquest_cross%3E1257863817%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1257863817&rft_id=info:pmid/11799479&rft_els_id=S1527646502022207&rfr_iscdi=true |